Table 1.
Baseline characteristics of patients with inflammatory bowel disease (IBD).
| Characteristic | N = 204 |
|---|---|
| Age (years) a | 34.6 (25, 41) |
| Gender | |
| Female | 85 (42%) |
| Male | 119 (58%) |
| Nationality | |
| Kuwaiti | 180 (88%) |
| Non-Kuwaiti | 24 (12%) |
| Disease extent, n (%) | |
| Ulcerative colitis (UC) | 64 (31.3%) |
| E1: ulcerative proctitis | 12 (18.7%) |
| E2: left sided colitis | 20 (31.2%) |
| E3: extensive colitis | 32 (50.0%) |
| Crohn's disease (CD) | 140 (68.7%) |
| L1: ileal | 62 (44.2%) |
| L2: colonic | 24 (17.1%) |
| L3: ileocolonic | 48 (34.4%) |
| L4: upper gastrointestinal | 6 (4.3%) |
| B1: inflammatory | 68 (48.8%) |
| B2: structuring | 33 (23.3%) |
| B3: penetrating | 39 (27.7%) |
| Past medical history | |
| Diabetes | 8 (3.9%) |
| Hypertension | 5 (2.0%) |
| Heart disease | 5 (2.0%) |
| Arthritis | 11 (5.0%) |
| COPD | 2 (1.0%) |
| Kidney | 5 (2.0%) |
| Asthma | 16 (8.0%) |
| Hyperlipidemia | 7 (3.0%) |
| IBD medications | |
| 5-aminosalicylates | 47 (23.0%) |
| Immunomodulators | 75 (37.0%) |
| Biologics and small molecules | 82 (40.0%) |
a
Median (IQR) or frequency (%).